The risk of gastric cancer in carriers of CHEK2 mutations (Q45259012)

11 December 2017

The risk of gastric cancer in carriers of CHEK2 mutations (English)

1 reference

11 December 2017

Teresa Starzyńska

5

0 references

Anna Jakubowska

object named as

Anna Jakubowska

4

0 references

Jan Lubiński

13

object named as

Jan Lubiński

1 reference

11 December 2017

2

Cezary Cybulski

1 reference

11 December 2017

12

Steven A Narod

1 reference

11 December 2017

9

Krzysztof Marlicz

1 reference

11 December 2017

1

Urszula Teodorczyk

1 reference

11 December 2017

6

Małgorzata Lawniczak

1 reference

11 December 2017

7

Paweł Domagała

1 reference

11 December 2017

3

Dominika Wokołorczyk

1 reference

11 December 2017

Katarzyna Ferenc

8

1 reference

11 December 2017

Zbigniew Banaszkiewicz

10

1 reference

11 December 2017

Rafał Wiśniowski

11

1 reference

11 December 2017

1 September 2013

1 reference

11 December 2017

1 reference

11 December 2017

12

1 reference

11 December 2017

3

1 reference

11 December 2017

473-478

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-012-9599-2

11 December 2017

0 references

cites work

Family history and the risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

21 January 2018

The Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Mutations in CHEK2 associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

CHEK2 I157T associates with familial and sporadic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

An inherited NBN mutation is associated with poor prognosis prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

Absence of germline CHK2 mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9599-2

CHEK2 variants associate with hereditary prostate cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23296741

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23296741

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23296741

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10689-012-9599-2

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference